BGIM
GMED icon

Brandywine Global Investment Management’s Globus Medical GMED Stock Holding History

Brandywine Global Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40,241
Closed -$2.76M – 690
2024
Q2 		$2.76M Sell
40,241
-89,640
-69% -$5.36M 0.02% 512
2024
Q1 		$6.97M Buy
129,881
+4,312
+3% +$232K 0.05% 348
2023
Q4 		$6.69M Buy
125,569
+27,735
+28% +$1.35M 0.05% 337
2023
Q3 		$4.86M Sell
97,834
-4,011
-4% -$224K 0.04% 372
2023
Q2 		$6.06M Buy
101,845
+6,618
+7% +$377K 0.05% 337
2023
Q1 		$5.39M Buy
95,227
+2,585
+3% +$166K 0.04% 365
2022
Q4 		$6.88M Buy
92,642
+24,490
+36% +$1.67M 0.05% 305
2022
Q3 		$4.06M Buy
68,152
+32,771
+93% +$1.97M 0.04% 382
2022
Q2 		$1.99M Sell
35,381
-116
-0.3% -$7.63K 0.02% 538
2022
Q1 		$2.62M Sell
35,497
-51
-0.1% -$3.54K 0.02% 507
2021
Q4 		$2.57M Sell
35,548
-265
-0.7% -$19.2K 0.02% 494
2021
Q3 		$2.74M Sell
35,813
-34
-0.1% -$2.73K 0.02% 492
2021
Q2 		$2.78M Sell
35,847
-15
-0% -$1.07K 0.02% 497
2021
Q1 		$2.21M Sell
35,862
-17
-0% -$1.08K 0.02% 514
2020
Q4 		$2.34M Sell
35,879
-13,515
-27% -$777K 0.02% 471
2020
Q3 		$2.45M Sell
49,394
-232
-0.5% -$12K 0.02% 437
2020
Q2 		$2.37M Sell
49,626
-153
-0.3% -$7.38K 0.02% 439
2020
Q1 		$2.12M Buy
49,779
+7,888
+19% +$390K 0.03% 428
2019
Q4 		$2.49M Sell
41,891
-103
-0.2% -$5.59K 0.02% 501
2019
Q3 		$2.15M Sell
41,994
-29,806
-42% -$1.42M 0.02% 520
2019
Q2 		$3.04M Buy
71,800
+2,938
+4% +$128K 0.02% 480
2019
Q1 		$3.4M Sell
68,862
-14,050
-17% -$636K 0.02% 453
2018
Q4 		$3.59M Sell
82,912
-1,992
-2% -$99.4K 0.03% 434
2018
Q3 		$4.82M Buy
84,904
+231
+0.3% +$12.2K 0.03% 429
2018
Q2 		$4.27M Sell
84,673
-3,132
-4% -$163K 0.03% 458
2018
Q1 		$4.38M Sell
87,805
-86,659
-50% -$4.07M 0.03% 459
2017
Q4 		$7.17M Sell
174,464
-122,235
-41% -$4.28M 0.04% 360
2017
Q3 		$8.82M Buy
296,699
+57,240
+24% +$1.75M 0.06% 311
2017
Q2 		$7.94M Buy
239,459
+91,742
+62% +$2.88M 0.05% 328
2017
Q1 		$4.38M Buy
+147,717
New +$4.03M 0.03% 473

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Brandywine Global Investment Management's GMED Position: Q3 2024 in Review

Brandywine Global Investment Management sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 40,241 shares — an estimated $2.76M sold.

Brandywine Global Investment Management first reported a position in GMED in Q1 2017 and held it in 30 quarters. The position peaked at $8.82M in Q3 2017. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Brandywine Global Investment Management reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
  • Brandywine Global Investment Management sold 40,241 Globus Medical shares in Q3 2024, an estimated $2.76M.
  • Brandywine Global Investment Management first reported a position in Globus Medical in Q1 2017 and held it in 30 quarters.
  • Brandywine Global Investment Management's Globus Medical position peaked at $8.82M in Q3 2017.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Brandywine Global Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.